PyInvesting

Market research

002727.SHE Yixintang Pharmaceutical Group Co., Ltd

SHE CNY Healthcare

Latest close

— —

Loading market data…

Test a moving-average rule with historical data.

Market facts
Market cap
6B
P/E ratio
22.83
Analyst target
13.19
Dividend yield
3.5%
Beta
0.57

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 5 months ago

Yixintang Pharmaceutical Group Co., Ltd is currently in a long term downtrend where the price is trading 15.3% below its 200 day moving average.

From a valuation standpoint, the stock is 78.2% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.1.

Yixintang Pharmaceutical Group Co., Ltd's total revenue rose by 21.3% to $3B since the same quarter in the previous year.

Its net income has increased by 55.1% to $186M since the same quarter in the previous year.

Finally, its free cash flow fell by 27.9% to $190M since the same quarter in the previous year.

Based on the above factors, Yixintang Pharmaceutical Group Co., Ltd gets an overall score of 3/5.